Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

18.70
Delayed Data
As of Feb 23
 +1.05 / +5.95%
Today’s Change
11.90
Today|||52-Week Range
18.99
+23.03%
Year-to-Date
No recent news for Vanda Pharmaceuticals Inc.

Today’s Trading

Previous close17.65
Today’s open18.15
Day’s range17.60 - 18.95
Volume1,277,004
Average volume (3 months)542,803
Market cap$849.7M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+14.63%
Earnings growth (this year)+282.86%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+13.06%
P/E ratioNM
Price/Sales4.12
Price/Book6.40

Competitors

 Today’s
change
Today’s
% change
CYTKCytokinetics Inc+0.10+1.28%
ACRSAclaris Therapeutics...+0.18+0.90%
FLXNFlexion Therapeutics...+1.07+4.42%
RVNCRevance Therapeutics...-0.20-0.65%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$165.1M
Annual profit (last year)-$15.6M
Net profit margin-9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts